Phase two of human trials is expected to begin within the coming months, expanding the pool of subjects to 50 and expanding the Gammora dosage period top three months.
The race is on.
BIT Price at posting:
14.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
